Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
38 studies found for:    " October 06, 2010":" November 05, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Withdrawn Depot Contraception With and Without Lopinavir/Ritonavir
Condition: HIV Infection
Intervention: Drug: DMPA
2 Completed
Has Results
Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients
Condition: HIV Infection
Intervention: Drug: Azithromycin
3 Completed Non-virologic Methods to Diagnose Treatment Eligibility in HIV-exposed Infants
Condition: HIV Infections
Intervention:
4 Unknown  Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART)
Condition: HIV Infection
Intervention: Drug: Hydroxychloroquine
5 Completed Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Condition: HIV
Intervention:
6 Completed Acceptability Study of Vaginal Films for HIV Prevention
Conditions: HIV Infections;   Anti-Infective Agents
Intervention: Other: No intervention (not applicable)
7 Completed
Has Results
Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks
Conditions: HIV Infections;   Heart Disease
Interventions: Drug: Rosuvastatin 10 mg. daily for 96 weeks;   Drug: Placebo
8 Completed HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir
Conditions: Chronic HIV Infection;   HCV Coinfection
Intervention: Drug: Fosamprenavir
9 Active, not recruiting Study to Improve Survival Among HIV-Exposed Infants in Botswana
Conditions: HIV Infections;   Neutropenia;   Anemia
Interventions: Drug: cotrimoxazole prophylaxis;   Drug: cotrimoxazole placebo;   Behavioral: exclusive breastfeeding until 6 months of age;   Behavioral: breastfeeding for 12 months
10 Unknown 
Has Results
A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily
Condition: Infection, Human Immunodeficiency Virus I
Interventions: Drug: GSK1349572 (dolutegravir);   Drug: raltegravir;   Other: GSK1349572 Placebo;   Other: ABC/3TC;   Other: TDF/FTC;   Other: raltegravir Placebo
11 Completed Epidemiology of Papillomavirus Infection (HPV) on Infected Women by Human Immunodeficience Virus (HIV) in West Indies and French Guiana.
Conditions: 1- Women;   2- HIV Infection;   3- Followed in West Indies and French Guiana for His Infection;   4- Acceptance of the Use of Nadis® Medical Files
Intervention: Other: Biological Sample collection
12 Completed Multi-vitamins, HAART and HIV/AIDS in Uganda
Condition: HIV/AIDS
Intervention: Dietary Supplement: Multivitamin supplements B,C and E
13 Unknown  Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)
Conditions: HIV Infection;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Protease Inhibitor;   Drug: Standard-of-care Antiretroviral therapy
14 Enrolling by invitation IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents
Conditions: ADHD;   HIV
Intervention:
15 Completed Effects of Cash Transfer for the Prevention of HIV in Young South African Women
Condition: HIV
Interventions: Behavioral: monthly cash transfer payments for attending school;   Behavioral: B--No cash transfers
16 Completed
Has Results
Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection
Condition: HIV
Interventions: Drug: Atazanavir;   Drug: Ritonavir;   Drug: Tenofovir (TDF);   Drug: Nucleoside Reverse Transcriptase Inhibitor (NRTI);   Drug: Famotidine (FAM)
17 Completed Vaginal Innate Immunity in Normal and HIV-Infected Women
Conditions: HIV;   Pregnancy
Intervention: Other: Vaginal lavage specimen
18 Completed Post-Exposure Prophylaxis in Health Care Workers
Condition: Human Immunodeficiency Virus
Intervention: Drug: emtricitabine/tenofovir disoproxil fumarate
19 Active, not recruiting Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV)
Conditions: HIV Infection;   Bone Loss;   Osteopenia;   Osteoporosis
Intervention: Drug: Zoledronic acid
20 Completed Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)
Conditions: Drug Interactions;   Human Immunodeficiency Virus
Intervention: Drug: Kaletra (lopinavir/ritonavir), African Potato (hypoxis obtusa)

   Previous Page Studies Shown (1-20) Next Page (21-38) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.